Evidence check: FOXO3 in the context of Haut

FOXO3 is a transcription factor regulating cell cycle, DNA repair, and antioxidant defense. In skin biology, FOXO3 is implicated in cellular senescence and protection against UV-induced damage. Reduced FOXO3 activity in dermal fibroblasts is linked to premature skin aging in vitro. However, direct human evidence connecting specific FOXO3 SNPs to skin aging phenotypes is limited to observational studies with small effect sizes. Consumer DNA tests often market FOXO3 variants (e.g., rs2802292) as predictors of skin aging, but such claims are not clinically validated. Lifestyle factors—sun exposure, diet, smoking—have far greater impact. The strongest human evidence for FOXO3 comes from longevity studies (e.g., in centenarians), not dermatology. Therefore, using a single SNP for skin advice is premature. Evidence grade: human-moderate (strong for longevity, moderate for skin mechanisms).